Reditux Injection: Product Description, Strengths, Benefits and Side Effects

Reditux Injection is a rituximab-based biological medicine supplied as a concentrate for intravenous infusion. Rituximab is a monoclonal antibody that targets CD20, a protein found on the surface of certain B lymphocytes. By binding to these cells, it helps the immune system eliminate targeted B cells.

Depending on the approved product information and clinical indication, rituximab may be used in the management of certain B-cell cancers and autoimmune conditions. Treatment decisions depend on the patient's diagnosis, medical history, and the applicable prescribing information.

For healthcare professionals and pharmaceutical procurement teams in Singapore, product verification should include the active ingredient, approved indications, formulation, storage requirements, manufacturer details, and applicable regulatory status.

Reditux Injection Strengths

Reditux presentations reported in pharmaceutical product references include the following intravenous infusion strengths:

Reditux 100 mg/10 mL: Contains 100 mg of rituximab in a 10 mL vial.

Reditux 500 mg/50 mL: Contains 500 mg of rituximab in a 50 mL vial.

These presentations correspond to a concentration of 10 mg/mL. Availability, packaging, and supply eligibility in Singapore must be confirmed against current product documentation and applicable Health Sciences Authority (HSA) requirements.

Reditux is not intended for self-administration. It must be prepared and administered by appropriately trained healthcare professionals in a suitable clinical setting.

Potential Benefits and Clinical Applications

Rituximab may be prescribed for specific conditions in accordance with the relevant approved product information. Potential clinical applications include:

Non-Hodgkin lymphoma: Used in selected treatment regimens for certain B-cell lymphomas.

Chronic lymphocytic leukaemia (CLL): May be used as part of a prescribed combination treatment.

Rheumatoid arthritis: May be considered for eligible patients whose disease has not responded adequately to certain previous treatments.

Selected autoimmune conditions: May be prescribed for conditions such as granulomatosis with polyangiitis and microscopic polyangiitis where authorised.

The expected clinical benefit varies by condition, treatment regimen, and individual patient. Rituximab does not guarantee a particular treatment outcome.

Reditux Injection Side Effects and Safety Information

Rituximab can cause side effects, and some may be serious. Common or recognised adverse effects include:

Infusion-related reactions, including fever, chills, and itching.

Nausea, headache, and fatigue.

Increased susceptibility to infections.

Changes in blood cell counts.

Skin reactions or allergic responses.

Serious risks include severe infusion reactions, hepatitis B reactivation, serious infections, and rare neurological complications such as progressive multifocal leukoencephalopathy (PML).

Before treatment, healthcare professionals should review the patient's medical history, infection status, current medicines, and vaccination history. Appropriate monitoring may include blood tests and hepatitis B screening. Urgent medical assessment is required for breathing difficulties, severe allergic symptoms, or signs of a serious infection.

Frequently Asked Questions (FAQs)

1. What is Reditux Injection used for?

Reditux contains rituximab, which may be used for certain B-cell cancers and autoimmune conditions, depending on the approved indication and treatment protocol.

2. What strengths of Reditux Injection are available?

Reported presentations include 100 mg/10 mL and 500 mg/50 mL. Confirm the exact presentation against current manufacturer documentation.

3. How is Reditux Injection administered?

It is administered through intravenous infusion by trained healthcare professionals. The dose, infusion schedule, and any accompanying medicines depend on the prescribed treatment regimen.

4. What are the major precautions?

Important precautions include infusion reactions, infections, hepatitis B reactivation, and blood cell abnormalities. Clinical assessment and appropriate monitoring are essential.

5. Can Reditux Injection be supplied in Singapore?

Supply depends on applicable Singapore registration, importation, licensing, and prescribing requirements. Verify the product's status with the relevant authorities before arranging supply.

Regulatory and Product Information Notice

Cordium Pharmaceuticals Pvt Ltd should ensure that all product information is accurate, current, and supported by approved documentation. Singapore restricts public advertising of prescription-only medicines; this material should therefore be reviewed for lawful use in an appropriate healthcare-professional or trade context before publication.